Floatz logo

Edoxaban

Pulmonary Embolism (PE)

Humanis Saglık Anonim SirketiSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Pulmonary Embolism (PE) cohort.

Asset / SponsorPhaseRating
Apixaban
Medical University of Gdansk
Phase 3BB
Tranexamic Acid
Albert Einstein College of Medicine
Phase 4BB
FONDAPARINUX
Johns Hopkins University
Phase 2BB
HEPARIN
Johns Hopkins University
Phase 4B
Enoxaparin
Medical University of Gdansk
Phase 1/2B

View all 14 →

Same molecule, other indications

Edoxaban is also rated in:

atrial fibrillationDormant
A
Indicative ·
83 / 100
View asset →
intracerebral hemorrhageDormant
BBB
Indicative ·
78 / 100
View asset →
EmbolismDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →